HIV Drug-Resistant Patient Information Management, Analysis, and Interpretation
- PMID: 23611761
- PMCID: PMC3626142
- DOI: 10.2196/resprot.1930
HIV Drug-Resistant Patient Information Management, Analysis, and Interpretation
Abstract
Introduction: The science of information systems, management, and interpretation plays an important part in the continuity of care of patients. This is becoming more evident in the treatment of human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS), the leading cause of death in sub-Saharan Africa. The high replication rates, selective pressure, and initial infection by resistant strains of HIV infer that drug resistance will inevitably become an important health care concern. This paper describes proposed research with the aim of developing a physician-administered, artificial intelligence-based decision support system tool to facilitate the management of patients on antiretroviral therapy.
Methods: This tool will consist of (1) an artificial intelligence computer program that will determine HIV drug resistance information from genomic analysis; (2) a machine-learning algorithm that can predict future CD4 count information given a genomic sequence; and (3) the integration of these tools into an electronic medical record for storage and management.
Conclusion: The aim of the project is to create an electronic tool that assists clinicians in managing and interpreting patient information in order to determine the optimal therapy for drug-resistant HIV patients.
Keywords: Bioinformatics; HIV drug resistance; Machine Learning; Medical Informatics.
Conflict of interest statement
Conflicts of Interest: None declared.
Similar articles
-
Machine Learning to Improve the Effectiveness of ANRS in Predicting HIV Drug Resistance.Healthc Inform Res. 2017 Oct;23(4):271-276. doi: 10.4258/hir.2017.23.4.271. Epub 2017 Oct 31. Healthc Inform Res. 2017. PMID: 29181236 Free PMC article.
-
Electronic health information technology as a tool for improving quality of care and health outcomes for HIV/AIDS patients.Int J Med Inform. 2012 Oct;81(10):e39-45. doi: 10.1016/j.ijmedinf.2012.06.006. Epub 2012 Aug 11. Int J Med Inform. 2012. PMID: 22890224
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
-
Human immunodeficiency virus infection, Part I.Dis Mon. 1998 Oct;44(10):545-606. doi: 10.1016/s0011-5029(98)90014-1. Dis Mon. 1998. PMID: 9814367 Review.
-
Predicting response to antiretroviral treatment by machine learning: the EuResist project.Intervirology. 2012;55(2):123-7. doi: 10.1159/000332008. Epub 2012 Jan 24. Intervirology. 2012. PMID: 22286881 Review.
References
-
- Albert D, Altfeld M, Aries SP, Behrens G, Bredeek UF, Buhk T, Dickinson L, Eggers C, Fätkenheuer G, Korsman S. HIV medicine 2007. Paris: Flying Publisher; 2007. [2012-05-15]. 67fr16R85 Pathogenesis of HIV-1 Infection http://www.hivmedicine.com/hivmedicine2007.pdf.
-
- Quinn TC. Molecular variants of HIV-1 and their impact on vaccine development. Int J STD AIDS. 1998;9 Suppl 1:2. - PubMed
-
- Kanki PJ, Hamel DJ, Sankalé JL, Hsieh C, Thior I, Barin F, Woodcock SA, Guèye-Ndiaye A, Zhang E, Montano M, Siby T, Marlink R, NDoye I, Essex ME, MBoup S. Human immunodeficiency virus type 1 subtypes differ in disease progression. J Infect Dis. 1999 Jan;179(1):68–73. doi: 10.1086/314557. http://www.jid.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=9841824 - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials